Evaluation of a SARS-CoV-2 test strategy in a southwestern university hospital at the beginning of the COVID-19 pandemic

被引:0
|
作者
Trimborn, Anna [1 ,2 ]
Gerigk, Marlis [2 ]
Heininger, Alexandra [1 ]
Santhanam, Nandhini [3 ]
Walter, Thomas [4 ]
Lange, Bettina [1 ]
机构
[1] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Stabsstelle Krankenhaushyg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[2] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Inst Med Mikrobiol & Hyg, Mannheim, Germany
[3] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Heinrich Lanz Zentrum Digitate Gesundheit, Mannheim, Germany
[4] Heidelberg Univ, Univ Med Mannheim, Med Fak Mannheim, Zentrale Notaufnahme, Mannheim, Germany
关键词
Guideline; Testing criterias; Testing capacities; Robert Koch Institute; Geovisualisation;
D O I
10.1007/s00103-021-03287-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background At the beginning of the COVID-19 pandemic, the German Robert Koch Institute (RKI) published several guidelines addressing the medical health services helping to detect SARS CoV-2. Needing an available and specific test strategy regarding SARS-CoV-2, our own test strategy strictly followed these testing criteria. Materials and methods Using a retrospective analysis, we verified if such a test strategy was an effective tool in the context of infection prevention control and as reliable SARS-CoV-2 detection. Therefore, we analysed our own test results of suspected SARS-CoV-2 cases between 26 February and 6 April 2020. Additionally, we used a geovisualisation tool to visualise test frequencies and positive test results within different districts of Mannheim based on people's addresses. Results There were on average 7% positive test results of SARS-CoV-2 within a population with typical symptoms of COVID-19 (n = 2808). There was no positive test result within an asymptomatic population (n = 448). However, one positive test result turned out to be a nosocomial infection. Finally, geovisualisation highlighted a shift of test frequencies and local positive rates for SARS-CoV-2 from one district of Mannheim to another. Discussion In conclusion, our test strategy strictly based on testing criteria suggested by the Robert Koch Institute resulted in a steady rate of positive tests and allowed us to increase test capacity without causing numbers of nosocomial infections of COVID-19. Geovisualisation tools can offer support in analysing an ongoing spread of transmissible diseases. In the future, they could be used as helpful tools for infection prevention control, for example in the context of vaccination programs.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 50 条
  • [41] SARS-CoV-2, COVID-19, and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 629 - 630
  • [42] Delirium and SARS-CoV-2/COVID-19
    von Arnim, C.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [43] SARS-CoV-2, COVID-19 and Neurodegeneration
    Toenges, Lars
    Klebe, Stephan
    BRAIN SCIENCES, 2022, 12 (07)
  • [44] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01): : 70 - 80
  • [45] In-hospital cardiovascular evaluation of COVID-19 patients during SARS-CoV-2 pandemic: results from a systematic approach
    Birtolo, Lucia Ilaria
    Maestrini, Viviana
    Galea, Nicola
    Severino, Paolo
    Infusino, Fabio
    Galardo, Gioacchino
    Ceccarelli, Giancarlo
    Alessandri, Francesco
    Palange, Paolo
    Colaiacomo, Maria Chiara
    Mastroianni, Claudio M.
    Chimenti, Cristina
    Frustaci, Andrea
    DEttorre, Gabriella
    Ruberto, Franco
    Catalano, Carlo
    Pugliese, Francesco
    Francone, Marco
    Mancone, Massimo
    Fedele, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N66 - N67
  • [46] Evaluation of COVID-19 Antigen Fluorescence Immunoassay Test for Rapid Detection of SARS-CoV-2
    Kiro, Vandana Vijayeta
    Gupta, Ankesh
    Singh, Parul
    Sharad, Neha
    Khurana, Surbhi
    Prakash, S.
    Dar, Lalit
    Malhotra, Rajesh
    Wig, Naveet
    Kumar, Arvind
    Trikha, Anjan
    Mathur, Purva
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2021, 13 (02) : 91 - 93
  • [47] SARS-CoV-2 antigen rapid detection tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination
    Wagenhaeuser, Isabell
    Knies, Kerstin
    Pscheidl, Tamara
    Eisenmann, Michael
    Flemming, Sven
    Petri, Nils
    Mcdonogh, Miriam
    Scherzad, Agmal
    Zeller, Daniel
    Gesierich, Anja
    Seitz, Anna Katharina
    Taurines, Regina
    Ernestus, Ralf-Ingo
    Forster, Johannes
    Weismann, Dirk
    Weissbrich, Benedikt
    Liese, Johannes
    Hartel, Christoph
    Kurzai, Oliver
    Doelken, Lars
    Gabel, Alexander
    Krone, Manuel
    EBIOMEDICINE, 2024, 109
  • [48] SARS-Cov-2 in peritoneal fluid: an important finding in the Covid-19 pandemic
    Barberis, A.
    Rutigliani, M.
    Belli, F.
    Ciferri, E.
    Mori, M.
    Filauro, M.
    BRITISH JOURNAL OF SURGERY, 2020, 107 (10) : E376 - E376
  • [49] A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
    Al-Awwal, Nasruddeen
    Dweik, Ferris
    Mahdi, Samira
    El-Dweik, Majed
    Anderson, Stephen H.
    PATHOGENS, 2022, 11 (03):
  • [50] COVID-19 pandemic crisis-a complete outline of SARS-CoV-2
    Shaikh, Sana Saffiruddin
    Jose, Anooja P.
    Nerkar, Disha Anil
    Vijaykumar KV, Midhuna
    Shaikh, Saquib Khaleel
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)